Christos S. Mantzoros - Publications, H-index & Citations

Back

Christos S. Mantzoros

harvard medical school

142H-index

960Paper Count

7.9WCitation Count

Published Papers 594

Publication Date

Repurposing GLP-1 receptor agonists and SGLT-2 inhibitors in neurodegeneration and metabolically at-risk populations: Myth or reality? An overview of randomized clinical trials

Diabetes Research and Clinical Practice

IF7.4

2026-05-27

PREAI

Michail-Angelos Mourtzos; Dimitrios Patoulias; Natalia-Maria Keklikoglou; Paschalis Karakasis; Valeria Gutierrez de Piñeres; Konstantinos Stefanakis; Manfredi Rizzo; Christos S. Mantzoros

Save

Proteomic Profiling of Plasma to Uncover Novel Intervention Targets and Prognostic Biomarkers for Chronic Liver Diseases

diabetes, obesity and metabolism

IF0

2026-03-26

OAAI

Xinxuan Li; Jing Sun; Jianhui Zhao; Fangyuan Jiang; Meng Zhang; Hao Wu; Shuai Yuan; Xue Li; Juan Lu; Christos S. Mantzoros

Save

Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin–activin–follistatin–IGF-1 axes: A 6-month long randomized placebo-controlled clinical trial

diabetes, obesity and metabolism

IF0

2026-01-23

PREAI

Arantxa Ramirez-Cisneros MD; Valeria Gutierrez de Piñeres MD; Claudia S. Tamayo-Torres MD; Konstantinos Stefanakis MD; Angeliki M. Angelidi MD; Lynn Fu BA; Georgia Anastasiou MD; Christos S. Mantzoros MD

Save

Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes

Smart Health

IF0

2026-01-01

OAAI

Deng, Yixiang; Arao, Kevin; Mantzoros, Christos S.; Karniadakis, George Em

Save

Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: a meta-analysis of randomized controlled trials

Metabolism

IF3.7

2025-12-03

OAAI

Paschalis Karakasis; Konstantinos Vlachos; Antonios P. Antoniadis; Konstantinos C. Siontis; Dimitrios Patoulias; Nikolaos Fragakis; Christos S. Mantzoros

Save

Comparative effectiveness of SGLT2 sodium-glucose cotransporter-2 inhibitors and GLP-1 glucagon-like peptide-1 receptor agonists for incident dementia: A retrospective multicohort study

Diabetes, Obesity and Metabolism

IF0

2025-11-27

OAAI

Filippos Anagnostakis MD; Michail Kokkorakis MD; Shrihari Nagarajan; Georgia Anastasiou MD; Christos S. Mantzoros MD

Save

Novel Machine-Learning Models Outperform Non-Invasive Tests in MASH with Fibrosis

Clinical Gastroenterology and Hepatology

IF12

2025-11-07

PREAI

Konstantinos Stefanakis; Geltrude Mingrone; Jacob George; Christos S. Mantzoros

Save

Sarcopenia and MASLD: novel insights and the future

Nature Reviews Endocrinology

IF31.8

2025-11-05

PREAI

Chang-Hai Liu; Qing-Min Zeng; Won Kim; Seung Up Kim; Zobair M. Younossi; Giovanni Targher; Christopher D. Byrne; Christos S. Mantzoros; Phunchai Charatcharoenwitthaya; Isabelle Anne Leclercq; Manuel Romero-Gómez; Hong Tang; Ming-Hua Zheng

Save

Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study

DIABETES OBESITY & METABOLISM

IF5.7

2025-11-01

PREAI

Gutierrez de Pineres, Valeria; Tamayo-torres, Claudia S.; Ramirez-cisneros, Arantxa; Kavelidou, Marianthi; Stefanakis, Konstantinos; Mantzoros, Christos S.

Save

Inter-organ crosstalk in health and cardiovascular-renal-hepatic-metabolic disease: A multidisciplinary perspective

Metabolism

IF3.7

2025-10-24

PREAI

Guanghong Jia; Christos S. Mantzoros; Michael A. Hill

Save

Semaglutide, the first approved GLP-1 receptor agonist for the management of metabolic dysfunction-associated steatohepatitis

Metabolism

IF3.7

2025-10-03

PREAI

Chrysoula Boutari; Michael A. Hill; Christos S. Mantzoros

Save

Best practice recommendations for the diagnosis and management of hypoparathyroidism

Metabolism

IF0

2025-06-26

PREAI

Aliya A. Khan; Dalal S. Ali; John P. Bilezikian; Sigridur Björnsdottir; Michael T. Collins; Natalie E. Cusano; Peter R. Ebeling; Ghada El Haj Fuleihan; Seiji Fukumoto; Andrea Giustina; Stephanie M. Kaiser; Christian A. Koch; Tayyab Khan; Patty Keating; Jian-Min Liu; Christos S. Mantzoros; Michael Mannstadt; Ambrish Mithal; Nancy D. Perrier; Michele Rayes; Maria Luisa Brandi

Save

Intranasal insulin enhances resting-state functional connectivity in Type 2 Diabetes

PLOS ONE

IF2.6

2025-05-20

OAAI

Zhang, Zongpai; Novak, Vera; Novak, Peter; Mantzoros, Christos; Ngo, Long; Lioutas, Vasileios

Save

Prediction models for the implementation of precision medicine in the real world. Some critical issues

Metabolism

IF0

2025-04-03

PREAI

Claudia Menzaghi; Massimiliano Copetti; Christos S. Mantzoros; Vincenzo Trischitta

Save

Association between remnant cholesterol and chronic kidney disease: Systematic review and meta-analysis

DIABETES OBESITY & METABOLISM

IF5.7

2025-02-14

OAAI

Karakasis, Paschalis; Patoulias, Dimitrios; Rizzo, Manfredi; Fragakis, Nikolaos; Mantzoros, Christos S.

Save

Accurate non-invasive detection of MASH with fibrosis F2-F3 using a lightweight machine learning model with minimal clinical and metabolomic variables

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2025-02-01

PREAI

Stefanakis, Konstantinos; Mingrone, Geltrude; George, Jacob; Mantzoros, Christos S.

Save

GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2025-02-01

PREAI

Kokkorakis, Michail; Folkertsma, Pytrik; Forte, Jose Castela; Wolffenbuttel, Bruce H. R.; van Dam, Sipko; Mantzoros, Christos S.

Save

Follistatins, activins and inhibins during osteoporosis therapy with denosumab or zoledronate and after their discontinuation

DIABETES OBESITY & METABOLISM

IF5.7

2025-01-23

PREAI

Anastasilakis, Athanasios D.; Makras, Polyzois; Polyzos, Stergios A.; Kumar, Ajay; Kalra, Bhanu; Mantzoros, Christos S.

Save

Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials

DIABETES OBESITY & METABOLISM

IF5.7

2025-01-15

PREAI

Ramirez-Cisneros, Arantxa; Stefanakis, Konstantinos; Mantzoros, Christos S.

Save

Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study

CLINICAL NUTRITION

IF7.4

2025-01-01

PREAI

Zeng, Qinglian; Luo, Xiaolin; Chen, Xiangjun; Luo, Wenjin; Li, Ruolin; Yang, Shumin; Yang, Jun; Shu, Xiaoyu; Li, Qifu; Hu, Jinbo; Ma, Linqiang; Mantzoros, Christos S.

Save

Research Directions